Literature DB >> 22785051

Inverse association between circulating levels of soluble receptor for advanced glycation end-products and coronary plaque burden.

Giuseppina Basta1, Serena Del Turco, Teresa Navarra, Alessandro Mazzarisi, Franca Cocci, Michele Coceani, Massimiliano Bianchi, Mathis Schlueter, Paolo Marraccini.   

Abstract

AIM: Low levels of soluble receptor for advanced glycation end-products (sRAGE) have been reported to be associated with coronary artery disease (CAD) and peripheral atherosclerosis. This study explored the relationship between circulating levels of sRAGE and the characteristics of coronary vessels detected by 64-slice computed tomography angiography (CTA).
METHODS: In this cross-sectional study we included 127 consecutive patients with CAD but without acute coronary syndrome. Quantitative volumetric analysis of the lumen and plaque burden of the vessel wall (soft and calcific components) was performed for the three major coronary vessels. Each component was expressed as a percentage of vessel volume and utilized in per-patient analysis. The patients were classified into two groups according to the presence of calcium volume: non-calcified plaque (NCP) group (calcium volume %=0) and calcified plaque (CP) group (calcium volume % >0).
RESULTS: In the NCP group, but not in the CP group, simple regression analysis revealed a negative association of total plaque burden % with sRAGE (β=-0.378, p=0.0019) and HDL cholesterol (β=-0.368, p=0.003) and a positive association with creatinine (β=0.258, p=0.041) and male gender (β=0.317, p=0.01). After adjusting for confounding factors, the total plaque burden % remained significantly associated only with sRAGE (β=-0.358, p=0.011).
CONCLUSIONS: Circulating sRAGE levels are associated in an inverse manner with non-calcified plaque burden, suggesting that it may be related with early atherosclerosis and plaque progression.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22785051     DOI: 10.5551/jat.10561

Source DB:  PubMed          Journal:  J Atheroscler Thromb        ISSN: 1340-3478            Impact factor:   4.928


  5 in total

1.  Advanced Glycation End Products:Receptors for Advanced Glycation End Products Axis in Coronary Stent Restenosis: A Prospective Study.

Authors:  Colin Pearce; Naorin Islam; Robyn Bryce; Erick Donnell McNair
Journal:  Int J Angiol       Date:  2018-10-29

Review 2.  Scavenger Receptors as Biomarkers and Therapeutic Targets in Cardiovascular Disease.

Authors:  Gary A Cuthbert; Faheem Shaik; Michael A Harrison; Sreenivasan Ponnambalam; Shervanthi Homer-Vanniasinkam
Journal:  Cells       Date:  2020-11-10       Impact factor: 6.600

3.  sRAGE and risk of diabetes, cardiovascular disease, and death.

Authors:  Elizabeth Selvin; Marc K Halushka; Andreea M Rawlings; Ron C Hoogeveen; Christie M Ballantyne; Josef Coresh; Brad C Astor
Journal:  Diabetes       Date:  2013-02-08       Impact factor: 9.461

4.  Relationship between advanced glycation end products and plaque progression in patients with acute coronary syndrome: the JAPAN-ACS sub-study.

Authors:  Yoshifumi Fukushima; Hiroyuki Daida; Takeshi Morimoto; Takatoshi Kasai; Katsumi Miyauchi; Sho-ichi Yamagishi; Masayoshi Takeuchi; Takafumi Hiro; Takeshi Kimura; Yoshihisa Nakagawa; Masakazu Yamagishi; Yukio Ozaki; Masunori Matsuzaki
Journal:  Cardiovasc Diabetol       Date:  2013-01-07       Impact factor: 9.951

5.  Soluble RAGE plasma levels in patients with coronary artery disease and peripheral artery disease.

Authors:  Colomba Falcone; Sara Bozzini; Luigina Guasti; Angela D'Angelo; Anna Clizia Capettini; Edoardo Maria Paganini; Rossana Falcone; Roberto Moia; Carmine Gazzaruso; Gabriele Pelissero
Journal:  ScientificWorldJournal       Date:  2013-10-09
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.